Position in GERN
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$402
New position
Shares Held
270
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $3,807,089 across 13 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
|
35,753 | $3,740,478 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
500 | $27,470 | |
| 3 | TLSA |
Tiziana Life Sciences Ltd
|
12,000 | $15,360 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
140 | $8,010 | |
| 5 | EXEL |
Exelixis, Inc.
|
100 | $5,441 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8 | $3,973 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3 | $1,870 | |
| 8 | CYTK |
Cytokinetics Inc
|
17 | $1,448 |
All Filings in GERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $402 | 270 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||